Dr. Hönle AG/€HNL
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Dr. Hönle AG
Dr. Hönle AG is a German company specializing in the industrial adhesives and drying technologies sector. The firm provides solutions across various industries including printing, medical technology, electronics, and glass processing. Key products and services include UV systems for curing inks, coatings, and adhesives, as well as systems for air, water, and surface disinfection. Founded in 1976, Dr. Hönle AG is headquartered in Gräfelfing, near Munich, Germany. The company's strategic strengths lie in its technological expertise and focus on innovation, allowing it to address complex industrial processes with customized solutions. Dr. Hönle AG operates on a global scale, serving diverse markets with a network of subsidiaries and distribution partners.
Ticker
€HNL
Sector
Primary listing
XETRA
Industry
Electrical Equipment
Headquarters
Employees
540
Website
Dr. Hönle AG Metrics
BasicAdvanced
€58M
-
-€2.14
1.45
-
Price and volume
Market cap
€58M
Beta
1.45
52-week high
€11.90
52-week low
€8.88
Average daily volume
5K
Financial strength
Current ratio
1.856
Quick ratio
0.735
Long term debt to equity
46.347
Total debt to equity
66.136
Interest coverage (TTM)
0.14%
Profitability
EBITDA (TTM)
4.669
Gross margin (TTM)
61.59%
Net profit margin (TTM)
-13.24%
Operating margin (TTM)
0.29%
Effective tax rate (TTM)
-7.43%
Revenue per employee (TTM)
€180,000
Management effectiveness
Return on assets (TTM)
0.11%
Return on equity (TTM)
-14.69%
Valuation
Price to revenue (TTM)
0.6
Price to book
0.73
Price to tangible book (TTM)
0.87
Price to free cash flow (TTM)
31.839
Free cash flow yield (TTM)
3.14%
Free cash flow per share (TTM)
30.40%
Growth
Revenue change (TTM)
-3.15%
Earnings per share change (TTM)
-9.85%
3-year revenue growth (CAGR)
-6.18%
10-year revenue growth (CAGR)
1.31%
3-year earnings per share growth (CAGR)
46.10%
10-year earnings per share growth (CAGR)
4.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Dr. Hönle AG stock?
Dr. Hönle AG (HNL) has a market cap of €58M as of July 25, 2025.
What is the P/E ratio for Dr. Hönle AG stock?
The price to earnings (P/E) ratio for Dr. Hönle AG (HNL) stock is 0 as of July 25, 2025.
Does Dr. Hönle AG stock pay dividends?
No, Dr. Hönle AG (HNL) stock does not pay dividends to its shareholders as of July 25, 2025.
When is the next Dr. Hönle AG dividend payment date?
Dr. Hönle AG (HNL) stock does not pay dividends to its shareholders.
What is the beta indicator for Dr. Hönle AG?
Dr. Hönle AG (HNL) has a beta rating of 1.45. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.